Search Results - "Bradley, John S."

Refine Results
  1. 1
  2. 2

    Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs by Le, Jennifer, Bradley, John S.

    Published in Journal of clinical pharmacology (01-10-2018)
    “…The selection of the right antibiotic and right dose necessitates clinicians understand the contribution of pharmacokinetic variability stemming from…”
    Get full text
    Journal Article
  3. 3

    Osteoarticular Infections in Children by Arnold, John C., MD, Bradley, John S., MD

    “…For a child with a suspected bone or joint infection, knowledge of the workup and initial therapy is important to provide quality care. Fever and pain are…”
    Get full text
    Journal Article
  4. 4

    Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America by Boucher, Helen W., Talbot, George H., Bradley, John S., Edwards, John E., Gilbert, David, Rice, Louis B., Scheld, Michael, Spellberg, Brad, Bartlett, John

    Published in Clinical infectious diseases (01-01-2009)
    “…The Infectious Diseases Society of America (IDSA) continues to view with concern the lean pipeline for novel therapeutics to treat drug-resistant infections,…”
    Get full text
    Journal Article
  5. 5

    Evaluation of acoustical conditions for speech communication in working elementary school classrooms by Sato, Hiroshi, Bradley, John S.

    “…Detailed acoustical measurements were made in 41 working elementary school classrooms near Ottawa, Canada to obtain more representative and more accurate…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults by Hendricks, Katherine A, Wright, Mary E, Shadomy, Sean V, Bradley, John S, Morrow, Meredith G, Pavia, Andy T, Rubinstein, Ethan, Holty, Jon-Erik C, Messonnier, Nancy E, Smith, Theresa L, Pesik, Nicki, Treadwell, Tracee A, Bower, William A

    Published in Emerging infectious diseases (01-02-2014)
    “…The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Improved vancomycin dosing in children using area under the curve exposure by Le, Jennifer, Bradley, John S, Murray, William, Romanowski, Gale L, Tran, Tu T, Nguyen, Natalie, Cho, Susan, Natale, Stephanie, Bui, Ivilynn, Tran, Tri M, Capparelli, Edmund V

    Published in The Pediatric infectious disease journal (01-04-2013)
    “…: Our objectives were to (1) determine the pharmacokinetic indices of vancomycin in pediatric patients; and (2) compare attainment of 2 target exposures: area…”
    Get full text
    Journal Article
  10. 10

    Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine by KAPLAN, Sheldon L, BARSON, William J, LING LIN, Philana, ROMERO, José R, BRADLEY, John S, TAN, Tina Q, HOFFMAN, Jill A, GIVNER, Laurence B, MASON, Edward O

    Published in The Pediatric infectious disease journal (01-03-2013)
    “…The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for routine administration to infants and children in 2010 in the United States. We have…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients by Avedissian, Sean N, Bradley, Erin, Zhang, Diana, Bradley, John S, Nazer, Lama H, Tran, Tri M, Nguyen, Austin, Le, Jennifer

    Published in Pediatric critical care medicine (01-09-2017)
    “…The objectives of this study were to: 1) evaluate the prevalence of augmented renal clearance in critically ill pediatric patients using vancomycin clearance;…”
    Get full text
    Journal Article
  15. 15

    Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States by Olarte, Liset, Kaplan, Sheldon L, Barson, William J, Romero, José R, Lin, Philana Ling, Tan, Tina Q, Hoffman, Jill A, Bradley, John S, Givner, Laurence B, Mason, Edward O, Hultén, Kristina G

    Published in Journal of clinical microbiology (01-03-2017)
    “…serotype 35B is a nonvaccine serotype associated with high rates of penicillin nonsusceptibility. An increase in the proportion of multidrug-resistant (MDR)…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    The use of systemic and topical fluoroquinolones by Bradley, John S, Jackson, Mary Anne

    Published in Pediatrics (Evanston) (01-10-2011)
    “…Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are…”
    Get full text
    Journal Article
  19. 19

    Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms by Shoji, Kensuke, Bradley, John S, Reed, Michael D, van den Anker, John N, Domonoske, Christine, Capparelli, Edmund V

    Published in Antimicrobial agents and chemotherapy (01-04-2016)
    “…The Clinical and Laboratory Standards Institute (CLSI) revised cefepime (CFP) breakpoints forEnterobacteriaceaein 2014, and MICs of 4 and 8 μg/ml were…”
    Get full text
    Journal Article
  20. 20

    Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children by KAPLAN, Sheldon L, BARSON, William J, LIN, Philana L, STOVALL, Stephanie H, BRADLEY, John S, TAN, Tina Q, HOFFMAN, Jill A, GIVNER, Laurence B, MASON, Edward O

    Published in Pediatrics (Evanston) (01-03-2010)
    “…The purpose of this study was to monitor the clinical and microbiologic features of invasive infections caused by Streptococcus pneumoniae among children…”
    Get full text
    Journal Article